Medicure Incis A Specialty Pharmaceutical Company Based In The U S Founded In 1997 And Publicly Traded Since 1999The Company Is Dedicated To Developing And Commercializing Innovative And Affordable Therapeutics For The U Smarkettrading Under The Symbol Mph On The Tsx Venture Exchange Medicure Aims To Become A Leading Pharmaceutical Company By Offering A Growing Portfolio Of Products That Enhance Patientslivesone Of Its Established Products Is Aggrastata Medication For Managing Acute Coronary Syndromethe Company Actively Explores Opportunities Within Its Pipeline And Considers Acquisitions To Expand Its Offeringsunder The Leadership Of Founder And Ceo Albert Dfriesenmedicure Focuses On Improving Patient Health And Access To Care
